[1]
“DIRECT ACTING ANTIVIRAL TREATMENT FOR PATIENTS WITH END STAGE KIDNEY DISEASE WITH ACUTE HCV INFECTION”, Mediterr J Hematol Infect Dis, vol. 11, no. 1, p. e2019034, Apr. 2019, doi: 10.4084/mjhid.2019.034.